Show Posts

This section allows you to view all posts made by this member. Note that you can only see posts made in areas you currently have access to.


Topics - Moonraker

Pages: 1 [2] 3 4 ... 7
16
I. Disruptive Technologies explained
What have the steam engine, the internet and smartphones
got in common? The emergence of all three technologies
listed by way of example triggered euphoria and a spirit of
optimism in industry and society. The steam engine heralded
the start of the industrial age, the internet drove forward digi-
talization while smartphones enable constant access to the
virtual world. All three technologies instigated an innovative
leap and radically changed their respective living and working
environments. Clayton M. Christensen from Harvard Business
School called technologies with such penetrating power “dis-
ruptive technologies”. Since the publication of the book “The
Innovators Dilemma” in 1995 and the scientific paper “Dis-
ruptive Technologies: Catching the Wave” the defining fea-
ture of a disruptive innovation is that it breaks up existing
market structures and dictates completely new ground rules
to the market.

II. What current technologies have that potential?
Umpteen investors ask themselves this question day in, day
out. A possible answer is provided by the Alpha 8 Global Dis-
ruptive Technology TR Index. The index provider Alpha 8 Part-
ners currently identifies ten industries with the potential to
create disruptive technology and thereby trigger innovative
leaps on a broad scale:

1.Robotics & Automation
2.3D Printing
3.Cyber Security
4.Solar Energy
5.Material Science & Battery Technology
6.Cloud Computing, Supercomputing & Big Data
7.Social Networking & Advanced Mobile Computing Technology
8.Biotechnology
9.Water Technology
10.Next Generation Lighting

See attachment(s) - I wouldn't mind putting some money in a fund like that.
Try and put some local share names next to points 1-10 if at all possible.
Orca would probably stick Metair next to #5 (Battery Technology). Maybe Rolfes next to #9 etc.

As to #1 specifically, the bad news for jobs is outlined HERE

17
Shares / Financial Mail Stock Picks 2016
« on: January 15, 2016, 04:41:07 pm »

18
Off topic / RBS says sell everything - deflationary crisis nears
« on: January 12, 2016, 01:35:27 pm »
RBS cries 'sell everything' as deflationary crisis nears

Scary stuff that has a 50/50 (?) chance of coming about.

19
Shares / Sanlam Private Wealth Stock Picks 2016
« on: December 13, 2015, 10:42:49 am »

20
Shares / Rights issue taken up and CGT implications
« on: December 12, 2015, 10:29:11 am »
Original shares held for 3 years+
Rights taken up for additional shares 10 months ago.
All shares sold.

In the UK the position for tax treatment is :-

Capital Gains Tax: Take Up Rights Issue
If you decide to take up the Rights Issue, it is treated as a "Share Reorganisation" by HMRC and the new shares are added to your existing holding, and are deemed to have been acquired at the same time and as your original share holding.


Can anyone confirm whether the same applies here ? (I think it probably does)

21
Shares / Vodacom sued for $14bn in Democratic Republic of Congo
« on: November 18, 2015, 05:19:32 pm »
Vodacom sued for $14bn in Democratic Republic of Congo

Quote
The claim relates to allegations by Conteh that Johannesburg-based Vodacom helped to undermine the businessman’s position as a statutory director of Congolese Wireless Network, which owns a 49% stake in Vodacom Congo. Conteh’s action in the Commercial Court of Kinshasa/Gombe also seeks to overturn a court decision stripping him of that position and to liquidate the Vodacom unit.

MTN - now VOD.  :o

22
Off topic / UK representative European Parliament - tells it like it is.
« on: October 17, 2015, 10:03:04 am »

23
Shares / Mediclinic - Al Noor merger
« on: October 14, 2015, 01:26:31 pm »
This looks like a very intricate arrangement and I hope someone can shed some light on it.
From what I gather MDC shreholders will receive 0.62500 new Al Noor shares for every MDC share held.
 MDC will be delisted. Then there will be a secondary JSE listing for the Al Noor shares, and on completion
of the arrangement Al Noor will be renamed "Mediclinic International plc" and the Enlarged
Group will have a premium listing on the Main Market of the London Stock Exchange, as
well as an inward secondary listing on the Main Board of the Johannesburg Stock
Exchange and, possibly, on the Namibian Stock Exchange.

Can someone enlighten me whether this is correct ?

You can see the details on sens. Here some extracts..

Quote
Recommended combination of Mediclinic International Limited and Al Noor Hospitals Group plc

Mediclinic International Limited
(Incorporated in the Republic of South Africa)
Registration number 1983/010725/06
Share Code: MDC
ISIN: ZAE000074142

Al Noor Hospitals Group Plc
(Incoporated in England and Wales)
Company Number 8338604
Share Code: ANH
ISIN: GB00B8HX8Z88

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO
ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION.

THE FOLLOWING ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR
PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY
INVESTMENT DECISION IN RELATION TO AL NOOR SHARES EXCEPT ON THE BASIS OF
THE INFORMATION IN THE AL NOOR CIRCULAR AND PROSPECTUSES, AND THE
MEDICLINIC CIRCULAR, THAT ARE PROPOSED TO BE PUBLISHED IN DUE COURSE.

14 October 2015

RECOMMENDED COMBINATION OF

AL NOOR HOSPITALS GROUP PLC

("Al Noor")

and

MEDICLINIC INTERNATIONAL LIMITED

("Mediclinic")

Further to the announcements made by Al Noor and Mediclinic on 5 October 2015 and 6 October 2015
respectively, in relation to their discussions regarding a possible combination of the two
companies, the board of Al Noor and the independent board of Mediclinic are pleased to announce
that they have reached agreement on the terms of a recommended combination of their respective
businesses (the "Combination").

KEY HIGHLIGHTS

-    Creation of a leading international private healthcare group with deep operational
     expertise and a well-balanced geographic profile in Southern Africa, Switzerland and the
     United Arab Emirates ("UAE"), as well as exposure to the UK market through a minority stake in
     Spire Healthcare Group plc.

-    Al Noor, as enlarged by the acquisition of Mediclinic (the "Enlarged Group"), will on a
     revenue basis be the third largest private healthcare provider in South Africa, the largest in
     the UAE and the largest private medical network in Switzerland.
     The Enlarged Group had pro-forma revenue of USD4 billion for the fiscal period 2014/15,
     comprising 46% from Switzerland, 31% from South Africa and 23% from the UAE(1).

-    The Enlarged Group will operate 73 hospitals with around 10,200 beds and 35 clinics, and
     will have nearly 32,000 employees.

-    The Combination is to be implemented by:

     -    Al Noor acquiring Mediclinic pursuant to a South African scheme of arrangement,
          under which Mediclinic shareholders will receive 0.62500 new Al Noor shares for
          each Mediclinic share held(2) as well as the Mediclinic interim dividend expected to
          be paid in December 2015;
and

     -    Al Noor shareholders:

          -    receiving a special dividend of GBP3.28 per Al Noor share; and

          -    having the opportunity to tender their shares to Al Noor for cancellation for a
               cash payment of GBP8.32 per Al Noor share (subject to scale back if more
               than 74,069,109 Al Noor shares are tendered).

-    An existing Al Noor shareholder that tenders its shares (and assuming no scale-back
     under the tender offer) will receive cash of GBP11.60 per Al Noor Share, which represents
     a premium of approximately 39% to the closing price of GBP8.35 per Al Noor share on 1 October 2015(3).

-    The Combination will result in Mediclinic shareholders owning 84% to 93% of the Enlarged
     Group, depending on take-up by existing Al Noor shareholders under the tender offer and
     before the subscription by Remgro for new Al Noor shares (described below) to part-fund
     the tender offer.

-    The cash payments to existing Al Noor shareholders in respect of the special dividend and
     tender offer will be partly funded through (i) a subscription by Remgro Limited or its wholly-
     owned subsidiary for 72,115,384 new Al Noor shares at a fixed price of
     GBP8.32 per share, to raise proceeds of GBP600 million; and (ii) a loan facility of up to
     GBP400 million.

-    Mediclinic expects the Combination to be earnings neutral to Mediclinic shareholders in
     the first full year of consolidation and accretive thereafter.(4)

-    On completion, Al Noor will be renamed "Mediclinic International plc" and the Enlarged
     Group will have a premium listing on the Main Market of the London Stock Exchange, as
     well as an inward secondary listing on the Main Board of the Johannesburg Stock
     Exchange and, possibly, on the Namibian Stock Exchange.




++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

14 October 2015

RECOMMENDED COMBINATION OF

AL NOOR HOSPITALS GROUP PLC

("Al Noor")

and

MEDICLINIC INTERNATIONAL LIMITED

("Mediclinic")

Further to the announcements made by Al Noor and Mediclinic on 5 October 2015 and 6 October
2015, respectively, in relation to their discussions regarding a possible combination of the two
companies, the board of Al Noor ("Al Noor Board") and the independent board of Mediclinic
("Mediclinic Board") are pleased to announce that they have reached agreement on the terms of
a recommended combination of their respective businesses (the "Combination").

1.     Principal terms of the Combination

Mediclinic

To effect the Combination, which will be subject to the approval of Al Noor shareholders and
Mediclinic shareholders and to the other conditions summarised below, and to the full terms and
conditions which will be set out in detail in the shareholder circular to be published by Mediclinic in
due course, Al Noor will acquire all of the shares in Mediclinic pursuant to a scheme of
arrangement of Mediclinic under section 114 of the South African Companies Act No. 71 of 2008
(the "SA Companies Act") (the "Mediclinic Scheme").

Under the terms of the Mediclinic Scheme, which will be governed by South African law, Mediclinic
shareholders on the register on the relevant record date will be entitled to receive:

for each Mediclinic Share                 0.62500 new Al Noor Shares

This ratio has been determined on the basis of the volume-weighted average trading price of Al
Noor ordinary shares ("Al Noor Shares") on the LSE and Mediclinic shares ("Mediclinic Shares")
on the JSE for the five trading days ending on and including 1 October 2015. The volume-
weighted average trading prices have been calculated with reference to the volume-weighted
average trading prices (in GBP) as reported by Factset and Capital IQ.

Under the terms of the Mediclinic Scheme, participating Mediclinic shareholders will be entitled to
elect either:

-      for their Mediclinic Shares to be repurchased, in consideration of which Mediclinic will be
       obliged to pay to the shareholder, in respect of each Mediclinic Share repurchased, a sum
       equal to the ZAR equivalent value of 0.62500 Al Noor Shares as at the effective date of
       the Mediclinic Scheme, on the basis that the Mediclinic shareholder's right to payment will
       be ceded to Al Noor in settlement of an obligation assumed by that shareholder under the
       Mediclinic Scheme to subscribe for 0.62500 new Al Noor Shares in respect of each
       Mediclinic Share repurchased (the "Repurchase Option"); or

-      for their Mediclinic Shares to be transferred to Al Noor, in consideration of the allotment
       and issue to them of 0.62500 new Al Noor Shares in respect of each Mediclinic Share
       transferred (the "Exchange Option")
.

The Repurchase Option will be the default position for all Mediclinic shareholders who are South
African incorporated companies that do not make an election, while the Exchange Option will be
the default position for all other Mediclinic shareholders that do not make an election.

The record date for determining the entitlement of Mediclinic shareholders to participate in the
Mediclinic Scheme will be determined and announced in due course, but will be shortly before the
Mediclinic Scheme becomes effective, which is expected to be in the first quarter of 2016.

Mediclinic shareholders will retain the interim dividend expected to be paid in December 2015.

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

15.     Termination of the Mediclinic listing on the JSE and Namibian Stock Exchange

Following the implementation of the Mediclinic Scheme, application will be made to the JSE to
terminate the listing of the Mediclinic Shares on the JSE and the Namibian Stock Exchange.

The secondary listing of the Enlarged Group on the JSE is expected to become effective, and
dealings in new Al Noor Shares on the JSE to commence, as soon as practicable after the
Mediclinic Scheme becomes effective. A listing for the Enlarged Group on the Namibian Stock
Exchange may also be sought, but is not a condition to the implementation of the Combination.



24
Off topic / Go global young man.. hmmpf
« on: August 19, 2015, 02:30:15 pm »
He..he..he.. grass not necessarily always greener on the other side. Would you buy SAB here (SA resident) or in UK (as UK resident) ? Here of course, thanks to the RAND YTD gain ± 14%.
In UK more or less FLAT.


25
Shares / Thoughts about a bankrupt Greece - possible consequences.
« on: June 16, 2015, 03:03:09 pm »
Although Greece accounts for less than 2% of EU GDP, a bankrupt state (or Grexit) could have serious repercussions.

1. Contagion. Italy, France, Spain, Portugal may need to implement (more) debt reducing measures. Risk premiums on for example Spanish bonds have already risen, pushing yields up sharply.
2. Confidence in the Euro as currency will take a knock.
3. The U.K. will realise that lender EU states will be obliged to provide huge rescue packages for Greece. Do they still want to be part of the EU ? (Nope).
4. Greece may forge much closer ties with Russia.
5. A crumbling Greek neighbour will help ISIS to destabilise the Balkan states - they are already at it.

So all in all, not a pretty picture.

27
Off topic / Eskom's long walk to freedom
« on: February 11, 2015, 05:13:42 pm »
 :-[


28
Shares / Is the Euro still a Rand Hedge ?
« on: January 07, 2015, 01:06:31 pm »
With deflation in Europe, exacerbated by the low oil prices, plus practically zero growth, the € is tanking and has lost heavily against the Rand on a yearly basis. So, be careful when selecting stocks that derive all their earnings from the Euro Zone ?
Your thoughts ?

The inflation rate in the euro area fell below zero for the first time in more
than five years, bolstering the case for more European Central Bank stimulus.

Prices dropped 0.2 percent in December, the European Union’s statistics office
in Luxembourg said today. That’s the lowest rate since September 2009.
Economists in a Bloomberg survey predicted a decline of 0.1 percent.
Unemployment held at 11.5 percent in November, Eurostat said in a separate report.

29
Off topic / What is this site talking about - US markets closed today ?
« on: October 13, 2014, 06:42:42 pm »
http://www.fin24.com/Markets/Currencies/Rand-firmer-as-US-holiday-offers-reprieve-20141013

Poor reporting, stupidity or what ? Markets are of course open.  :wtf:

30
Off topic / Market needs a bit of 'turbo shove'
« on: October 01, 2014, 01:43:23 pm »
Market needs a bit of a shove like this ....


Pages: 1 [2] 3 4 ... 7